DUBLIN--(BUSINESS WIRE)--The "Insulin Pen Market & Users by Diabetes Population (Type 1, Type 2), Countries, Types of Insulin Pen (Disposable, Reusable, Smart), Reimbursement Policies, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
An insulin pen is a medical device that is used by diabetic people to inject insulin. The device is consists of an insulin cartridge, a dial to measure the dose, and disposable pen needles to deliver the dose. Currently, there are 3 types of insulin pens available in the market (Disposable, Reusable, and Smart) insulin pen. According to this report, the Global Insulin Pen Market is expected to surpass US$ 35 Billion by the end of the year 2025.
Types of Insulin Pens
- A disposable insulin pen comes with pre-filled insulin. Once the insulin cartridge is over than the entire insulin pen is disposed. The disposable insulin pen is also called prefilled insulin pen.
- A reusable pen contains a replaceable insulin cartridge. So once the insulin cartridge is empty, than it needs to be replaced with a new one. A reusable insulin pen is also known as a durable insulin pen.
- Smart insulin pen is the Bluetooth enabled insulin pen that records the time/date of insulin injections that have been delivered. The recent addition to the pack Smart insulin pen is also known as a connected insulin pen.
Insulin Pen advantages over Syringe
According to various studies, research, and surveys, insulin pen has an advantage over conventional syringe or vials. In syringe, patients have to fill insulin themselves and have to pay a lot of attention while giving adequate units before injection. This could be a problem for aged patient who generally has weak eyesight, and they may face difficulties while filling the precise quantity of insulin.
The insulin pen eradicates these entire problems as it's safe and simple to use and convenient for aging population as they have the tendency to forget. Due to these advantages, people with diabetes are shifting from syringe to pen globally. Moreover, rising per capita income of diabetic people across the world is also increasing the acceptability of insulin pen over vials.
Growth Factors & Challenges of the Insulin Pen Market
The major factors that are fueling the growth of the insulin pen market are; rising diabetes population (especially type 2 diabetes population), increasing geriatric population, growth in obese population globally, etc. On the contrary, the challenges of the market growth are the availability of alternatives to insulin pens in the market and the high cost of insulin pens.
Diabetes Population
In this report, insulin pen markets are categorized based on diabetes population; Type 1 Diabetes population, and Type 2 Diabetes Population.
Insulin Pen - Disposable Insulin Pen holds significant Market Share
In this report, Insulin Pen Market is categorized based on pen-type; Disposable Insulin Pen, Reusable Insulin Pen, Smart Insulin Pen, and Insulin Pen Needle Market. Disposable Insulin Pen holds a significant market share.
All the companies have been studied from three points
- Overview
- Recent Developments
- Sales Analysis
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.2 Challenges
5. Global Insulin Pen Analysis
5.1 Market
5.2 User
6. Market & Volume Share Analysis
6.1 Market share
6.1.1 Types
6.1.2 Country
6.2 Volume Share
6.2.1 Insulin Pen Users
7. Market Analysis - By Types
7.1 Disposable Insulin Pen
7.2 Reusable Insulin Pen
7.3 Smart Insulin Pen
7.4 Insulin Pen Needle
8. United States
9. Germany
10. Sweden
11. United Kingdom
12. Netherlands
13. Switzerland
14. Australia
15. Saudi Arabia
16. China
17. India
18. Brazil
19. Company Analysis
19.1 B. Braun Melsungen AG
19.1.1 Overview
19.1.2 Initiatives & Recent Developments
19.1.3 Revenue
19.2 Eli Lilly and Company
19.2.1 Overview
19.2.2 Initiatives & Recent Developments
19.2.3 Revenue
19.3 Artsana S.p.A.,
19.3.1 Overview
19.3.2 Initiatives & Recent Developments
19.3.3 Revenue
19.4 BD
19.4.1 Overview
19.4.2 Initiatives & Recent Developments
19.4.3 Revenue
19.5 Novo Nordisk A/S
19.5.1 Overview
19.5.2 Initiatives & Recent Developments
19.5.3 Revenue
19.6 Owen Mumford Ltd.
19.6.1 Overview
19.6.2 Initiatives & Recent Developments
19.6.3 Revenue
19.7 Ypsomed AG
19.7.1 Overview
19.7.2 Initiatives & Recent Developments
19.7.3 Revenue
19.8 Terumo Corporation
19.8.1 Overview
19.8.2 Initiatives & Recent Developments
For more information about this report visit https://www.researchandmarkets.com/r/1g5r1q
